Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J-P Marie

Showing results (241-250 of 277) with videos related to

Pageof 28
Sort By:
The European Journal of Medicine|May 1, 1993
Should vancomycin be used empirically in febrile patients with prolonged and profound neutropenia? Results of a randomized trialJ L Pico, J P Marie, D Chiche, et al.
Nouvelle Revue Francaise D'Hematologie|January 1, 1994
[Utilization of transfusions in the hematology clinic. Recommendations of the Evaluation Commission of the French College of Hematologists for transfusion support in the treatment of acute leukemia in therapeutic aplasia]G Andreu, M Benbunan, M Boasson, et al.
Annales De Medecine Interne|January 1, 1983
[4 cases of acquired Willebrand factor deficiency associated with monoclonal dysglobulinemia]M H Horellou, E Baumelou, N Sitbon, et al.
British Journal of Haematology|February 5, 1998
Adult biphenotypic acute leukaemia: an entity with poor prognosis which is related to unfavourable cytogenetics and P-glycoprotein over-expressionO Legrand, J Y Perrot, G Simonin, et al.
British Journal of Haematology|June 1, 1992
Expression of multidrug resistance gene mdr1 mRNA in a subset of normal bone marrow cellsJ P Marie, N A Brophy, M N Ehsan, et al.
Nouvelle Revue Francaise D'Hematologie|August 1, 1994
[Antibiotic strategy for febrile episodes during severe (less than 500 PNN) and prolonged (greater than or equal to 7 days) neutropenia. Recommendations of the Evaluation Committee of the Collège Français des Hematologistes]C Cordonnier, G Leverger, B Schlemmer, et al.
Leukemia|September 14, 1999
Cyclin D1 overexpression allows identification of an aggressive subset of leukemic lymphoproliferative disorderV Levy, V Ugo, A Delmer, et al.
Leukemia|February 6, 2004
Incidence and prognostic value of respiratory events in acute leukemiaD Chaoui, O Legrand, N Roche, et al.
Leukemia & Lymphoma|November 1, 1994
Evaluation of the clinical relevance of the anionic glutathione-s-transferase (GST pi) and multidrug resistance (mdr-1) gene coexpression in leukemias and lymphomasD Russo, J P Marie, D C Zhou, et al.
Leukemia|January 1, 1992
Therapy of adult ALL: overview of 2 successive EORTC studies: (ALL-2 & ALL-3). The EORTC Leukemia Cooperative Study GroupP Stryckmans, T De Witte, J P Marie, et al.
Pageof 28

Showing results (241-250 of 277) with videos related to

Sort By:
Pageof 28
The European Journal of Medicine|May 1, 1993
Should vancomycin be used empirically in febrile patients with prolonged and profound neutropenia? Results of a randomized trialJ L Pico, J P Marie, D Chiche, et al.
Nouvelle Revue Francaise D'Hematologie|January 1, 1994
[Utilization of transfusions in the hematology clinic. Recommendations of the Evaluation Commission of the French College of Hematologists for transfusion support in the treatment of acute leukemia in therapeutic aplasia]G Andreu, M Benbunan, M Boasson, et al.
Annales De Medecine Interne|January 1, 1983
[4 cases of acquired Willebrand factor deficiency associated with monoclonal dysglobulinemia]M H Horellou, E Baumelou, N Sitbon, et al.
British Journal of Haematology|February 5, 1998
Adult biphenotypic acute leukaemia: an entity with poor prognosis which is related to unfavourable cytogenetics and P-glycoprotein over-expressionO Legrand, J Y Perrot, G Simonin, et al.
British Journal of Haematology|June 1, 1992
Expression of multidrug resistance gene mdr1 mRNA in a subset of normal bone marrow cellsJ P Marie, N A Brophy, M N Ehsan, et al.
Nouvelle Revue Francaise D'Hematologie|August 1, 1994
[Antibiotic strategy for febrile episodes during severe (less than 500 PNN) and prolonged (greater than or equal to 7 days) neutropenia. Recommendations of the Evaluation Committee of the Collège Français des Hematologistes]C Cordonnier, G Leverger, B Schlemmer, et al.
Leukemia|September 14, 1999
Cyclin D1 overexpression allows identification of an aggressive subset of leukemic lymphoproliferative disorderV Levy, V Ugo, A Delmer, et al.
Leukemia|February 6, 2004
Incidence and prognostic value of respiratory events in acute leukemiaD Chaoui, O Legrand, N Roche, et al.
Leukemia & Lymphoma|November 1, 1994
Evaluation of the clinical relevance of the anionic glutathione-s-transferase (GST pi) and multidrug resistance (mdr-1) gene coexpression in leukemias and lymphomasD Russo, J P Marie, D C Zhou, et al.
Leukemia|January 1, 1992
Therapy of adult ALL: overview of 2 successive EORTC studies: (ALL-2 & ALL-3). The EORTC Leukemia Cooperative Study GroupP Stryckmans, T De Witte, J P Marie, et al.
Pageof 28